Sanofi Tolebrutinib faces USFDA review delay; new target action date set for December 28
- 22 September 2025
- 1 month ago
Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapy
- 11 September 2025
- 1 month ago
Sanofi Tzield approved in China for adult, pediatric patients with stage 2 type 1 diabetes
- 10 September 2025
- 1 month ago
Autistic Children Mother Lodges Complaint Over Emissions From Sanofi Depakine Drug Plant: Report
- 24 July 2025
- 3 months ago
Recent News
Himachal notifies Resident doctor policy 2025
- 02 November, 2025
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Aadhaar authentication voluntary for NBE exams, cl...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.




